National Human Genome Research Institute; Notice of Meeting, 4155 [06-692]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices
Virology 2005, volume 29, pp 12394–
12400.
In addition to licensing, the
technology is available for further
studies in application to vaccine
development in animal models through
collaborative research opportunities
with the inventors. Please contact Dr.
Yossef Raviv at yraviv@ncifcrf.gov.
Dated: January 18, 2006.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E6–909 Filed 1–24–06; 8:45 am]
Dated: January 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–691 Filed 1–24–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Council for Human
Genome Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Initial Review
Group; Genome Research Review Committee.
Date: March 8–10, 2006.
Time: March 8, 2006, 7 p.m to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Time: March 9, 2006, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Time: March 10, 2006, 8:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Contact Person: Rudy O. Pozzatti, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Human Genome
Research Institute, National Institutes of
Health, Bethesda, MD 20892. 301–402–0838.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Name of Committee: National Advisory
Council for Human Genome Research.
Date: February 13–14, 2006.
Open: February 13, 2006, 8:30 a.m. to 2
p.m.
Agenda: To discuss matters of program
relevance.
Place: National Institutes of Health, 5635
Fisher Lane, Terrace Level Conference Room,
Rockville, MD 20892.
Closed: February 13, 2006, 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 5635
Fisher Lane, Terrace Level Conference Room,
Rockville, MD 20892.
Closed: February 14, 2006, 8:30 a.m. to 5
p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 5635
Fisher Lane, Terrace Level Conference Room,
Rockville, MD 20892.
Contact Person: Mark S. Guyer, PhD,
Director for Extramural Research, National
Human Genome Research Institute, 5635
Fisher Lane, Suite 4076, MSC 9305,
BILLING CODE 4167–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
wwhite on PROD1PC61 with NOTICES
National Human Genome Research
Institute; Notice of Closed Meeting
VerDate Aug<31>2005
18:26 Jan 24, 2006
Jkt 208001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
4155
Bethesda, MD 20892, 301–496–7531,
guyerm@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.genome.gov/11509849, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: January 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–692 Filed 1–24–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; ITV
Related Child Disorders.
Date: February 8–9, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Crystal City Hotel, 1800
Jefferson Davis Highway, Arlington, VA
22202. 703–386–1111.
Contact Person: Christopher S. Sarampote,
PhD, Scientific Review Administrator,
Division of Extramural Activities, National
Institute of Mental Health, NIH,
Neuroscience Center, 6001 Executive Blvd.,
Room 6148, MSC 9608, Bethesda, MD 20892–
9608. 301–443–1959.
csarampo@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
E:\FR\FM\25JAN1.SGM
25JAN1
]]>Agencies
[Federal Register Volume 71, Number 16 (Wednesday, January 25, 2006)]
[Notices]
[Page 4155]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-692]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Advisory Council for Human Genome Research.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Human Genome
Research.
Date: February 13-14, 2006.
Open: February 13, 2006, 8:30 a.m. to 2 p.m.
Agenda: To discuss matters of program relevance.
Place: National Institutes of Health, 5635 Fisher Lane, Terrace
Level Conference Room, Rockville, MD 20892.
Closed: February 13, 2006, 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, 5635 Fisher Lane, Terrace
Level Conference Room, Rockville, MD 20892.
Closed: February 14, 2006, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, 5635 Fisher Lane, Terrace
Level Conference Room, Rockville, MD 20892.
Contact Person: Mark S. Guyer, PhD, Director for Extramural
Research, National Human Genome Research Institute, 5635 Fisher
Lane, Suite 4076, MSC 9305, Bethesda, MD 20892, 301-496-7531,
guyerm@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.genome.gov/11509849, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: January 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-692 Filed 1-24-06; 8:45 am]
BILLING CODE 4140-01-M
